New trial tests if adding a blood thinner to standard care prevents heart attacks in rare artery condition
NCT ID NCT07511257
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two blood-thinning approaches in 326 adults with acute coronary syndrome and coronary artery ectasia (enlarged heart arteries). One group gets standard dual antiplatelet therapy (aspirin plus clopidogrel), while the other gets clopidogrel plus the anticoagulant rivaroxaban. The goal is to see if adding rivaroxaban reduces major heart events without causing too much bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aspirin, clopidogrel, and rivaroxaban
- What this could lead to
- If successful, this could establish a better blood-thinning strategy to prevent heart attacks and repeat procedures in people with both acute coronary syndrome and coronary artery ectasia.
- What could go wrong
- This is a phase 4 trial, but the condition is uncommon, so results may not apply broadly. Adding anticoagulation also raises the risk of bleeding, which could outweigh the benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES (ACS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Nacional de Cardiologia "Ignacio Chávez"
RECRUITINGMexico City, Tlalpan, 14080, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart rehab goes hybrid: can a mix of home and clinic sessions boost adherence?
- Widened heart arteries: a hidden threat to blood flow?
- Massive chest pain registry reveals gaps between guidelines and real-world care in china
- Simple arm cuff before angioplasty may boost heart attack recovery
- Suction device may improve outcomes in heart attack patients with large clots
- Fish oil derivative may calm heart inflammation and stabilize plaques